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Abstract
Objective—Quantitative resuscitation consists of structured cardiovascular intervention targeting
predefined hemodynamic end points. We sought to measure the treatment effect of quantitative
resuscitation on mortality from sepsis.
Data Sources—We conducted a systematic review of the Cochrane Library, MEDLINE,
EMBASE, CINAHL, conference proceedings, clinical practice guidelines, and other sources using
a comprehensive strategy.
Study Selection—We identified randomized control trials comparing quantitative resuscitation
with standard resuscitation in adult patients who were diagnosed with sepsis using standard criteria.
The primary outcome variable was mortality.
Data Abstraction—Three authors independently extracted data and assessed study quality using
standardized instruments; consensus was reached by conference. Preplanned subgroup analysis
required studies to be categorized based on early (at the time of diagnosis) vs. late resuscitation
implementation. We used the chi-square test and I2 to assess for statistical heterogeneity (p < 0.10,
I2 > 25%). The primary analysis was based on the random effects model to produce pooled odds
ratios with 95% confidence intervals.
Results—The search yielded 29 potential publications; nine studies were included in the final
analysis, providing a sample of 1001 patients. The combined results demonstrate a decrease in
mortality (odds ratio 0.64, 95% confidence interval 0.43–0.96); however, there was statistically
significant heterogeneity (p = 0.07, I2 = 45%). Among the early quantitative resuscitation studies (n
= 6) there was minimal heterogeneity (p = 0.40, I2 = 2.4%) and a significant decrease in mortality
(odds ratio 0.50, 95% confidence interval 0.37–0.69). The late quantitative resuscitation studies (n
= 3) demonstrated no significant effect on mortality (odds ratio 1.16, 95% confidence interval 0.60–
2.22).
Conclusion—This meta-analysis found that applying an early quantitative resuscitation strategy
to patients with sepsis imparts a significant reduction in mortality.
*See also p. 2932.
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Quantitative resuscitation in critically ill patients consists of structured cardiovascular
intervention with intravascular volume expansion and vasoactive agent support to achieve
explicit predefined physiologic or supraphysiologic end points. The concept of quantitative
resuscitation (also referred to as hemodynamic optimization, goal-oriented resuscitation, or
goal-directed therapy) as a treatment strategy to improve clinical outcome was first reported
by Shoemaker et al. (1) in high risk surgery patients. Since this sentinel report, multiple other
investigators have published randomized clinical trials investigating the effect of quantitative
resuscitation in various critically ill patient populations, including those with sepsis.
In the United States, 750,000 people experience severe sepsis each year, of whom 500,000
require intensive or intermediate level care, and 30% die (2). During the last 30 years numerous
new therapeutic strategies for severe sepsis have been investigated. Unfortunately, few
therapies have demonstrated significant reduction in mortality in patients with severe sepsis
(3). However, a randomized control trial of 263 patients by Rivers et al. (4) reported a 16%
absolute reduction in in-hospital mortality among severe sepsis and septic shock patients who
received early quantitative resuscitation when compared with standard resuscitation. As a result
of this trial, the Surviving Sepsis Campaign guidelines recommend that a quantitative
resuscitation strategy should be implemented at the time of recognition of severe sepsis (5).
Despite its endorsement by 11 professional societies, the recommendation has produced
significant controversy, in part because it relied heavily on one study (6–10).
Scientific knowledge is cumulative; therefore new research findings should be interpreted
based on what is already known (11). Recognizing that clinical trials of quantitative
resuscitation were published for nearly two decades before the Rivers et al. study, we
hypothesized that their results could be aggregated to produce more definitive conclusions
about the treatment effect of quantitative resuscitation in sepsis. Therefore, we conducted a
meta-analysis to examine the available evidence investigating a quantitative resuscitation
strategy for patients with sepsis, to determine the treatment effect of such a strategy on
mortality, and to determine whether the timing of implementation of quantitative resuscitation
impacts mortality.
METHODS
Search Strategy for Identification of Studies
A written protocol following recommended guidelines that was finalized before beginning the
study was followed (12). We searched the Cochrane Library, MEDLINE (1965–August 2007),
EMBASE (1974–August 2007), and CINHAL (1982–August 2007) using the search terms
(sepsis or septic shock or severe sepsis or critical care) and (hemodynamics or resuscitation
or resuscitation end points or oxygen delivery or goal-oriented therapy or goal-directed
resuscitation or early goal-directed therapy) and clinical trial. The search was updated in April
2008. To identify potential unpublished data we contacted two experts in the field of sepsis
resuscitation, we hand searched abstracts from the Society of Critical Care Medicine, American
College of Chest Physicians, American College of Emergency Physicians and Society for
Academic Emergency Medicine annual meetings from 1997 to 2007, we reviewed published
practice guidelines for sepsis care from 2000 to 2007, and searched websites containing details
for clinical trial registration. Additionally, reference lists of the articles chosen for inclusion
and the reference lists of previous reviews (13–18) were screened to identify further studies
for inclusion.
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Inclusion Criteria
We considered studies eligible for review regardless of language or publication type, if they
were randomized control trials of adults (age >17 yr) with a presumptive or confirmed diagnosis
of sepsis who were treated in an experimental study using: 1) a clearly defined intervention
consisting of a structured cardiovascular resuscitation protocol administered to achieve
predefined hemodynamic end points; and 2) a control group in which subjects received standard
of care therapy. We included subpopulations of sepsis patients from studies with large
heterogeneous populations, if the subpopulations met our inclusion criteria. Reviews,
correspondence, editorials, and nonhuman studies were excluded; however, their reference lists
were screened to identify further studies for inclusion. We attempted to contact corresponding
authors for clarification of data extraction or quality assessment if not clear from the published
article or abstract.
Study Selection and Data Abstraction
Two independent reviewers (A.E.J. and J.S.G.) screened the titles and abstracts of identified
studies for potential eligibility (19). After the relevance screen the two reviewers compared
their exclusion logs to determine whether there was disagreement; the Kappa statistic was used
to assess interobserver agreement. In cases of disagreement, a third reviewer assessed the
abstract and a consensus was reached by conference between the three reviewers. All studies
deemed potentially relevant were obtained and the full manuscripts were reviewed for
inclusion. Three reviewers (J.A.K., N.I.S., S.T.) independently abstracted data on all patient
populations, interventions, and outcomes using a standardized data collection form. Any
disagreements in these processes were resolved by consensus.
Assessment of Quality
Study quality was assessed using two major categories:
1. Appropriate patient selection by identification of sepsis using accepted diagnostic
criteria (20): grade A—used standard criteria, grade B—used nonstandard criteria,
grade C—unknown.
2. Internal validity assessment based on concealment of allocation: grade A—adequate,
grade B—unclear, grade C—inadequate. The Cochrane Handbook (12) provides
definitions for each category as follows: grade A—allocation concealment was
adequately reported (centralized randomization either by a central office; sequential
administration of coded containers to enrolled participants; on-site computer; serially
numbered sealed opaque envelopes); grade B—allocation concealment is not
described, but it is mentioned in the text that the study is randomized; grade C—
allocation concealment was inadequate (alternation; dates of birth; days of the week;
any allocation that is entirely transparent before allocation).
Blinding was not considered essential because it was recognized that masking clinicians and
patients from a complex intervention such as a quantitative resuscitation protocol would be
extremely difficult. In addition, the potential for measurement bias was minimal given that the
primary outcome was death.
Main Outcome Measure
We defined mortality at the end of the time frame reported by the authors to be the primary
dependent variable for analysis. In that event, authors reported mortality at more than one time
point we used in-hospital mortality preferentially.
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Primary Statistical Analysis
All data were entered into Review Manager Software (version 4.2. Copenhagen: The Nordic
Cochrane Centre, The Cochrane Collaboration, 2003). Heterogeneity was tested using a chi-
square test with a p value <0.10 to indicate significant heterogeneity between the trials. In
addition, I2 was calculated to provide an estimate of the variability across studies beyond that
due to chance (21). The results of studies were pooled using a random effects model. The
individual and pooled statistics were calculated as odds ratios (OR) with 95% confidence
intervals (CI). We constructed a funnel plot and performed Egger regression (22) to detect the
presence of publication bias. However, the authors acknowledge that statistical tests used to
identify publication bias have low power and any asymmetry identified in a funnel plot may
be the result of numerous factors other than publication bias (23,24).
Subgroup and Sensitivity Analyses
We hypothesized that studies implementing early quantitative resuscitation, defined as therapy
implemented at the time of recognition of sepsis or within 24 hr, may have different results
than studies that reported late quantitative resuscitation (initiated after 24 hr or unknown/
unreported timing). Considering this obvious clinical heterogeneity, subgroup analysis was
planned a priori for these two groups of studies based on timing to quantitative resuscitation
intervention (early vs. late). We also planned sensitivity analysis to determine whether
including only studies with high quality of conduct or reporting yielded different results.
Studies reporting adequate concealment of allocation (grade A) were considered “high
quality.” In addition, we performed a post hoc (not described in our original protocol)
sensitivity analysis in which we excluded each study individually and reanalyzed the pooled
OR among the early subgroup to determine whether any individual study may be influencing
the results. Finally, a sensitivity analysis was performed to examine the use of a fixed effect
vs. random effects model.
RESULTS
Search and Selectio
The comprehensive search yielded a total of 903 relevant publications; details of the search
and study selection are shown in Figure 1 and Table 1.
Inclusion
After the relevance search (blinded interobserver agreement 98.7% with 12 disagreements of
903 articles, κ = 0.7) a complete manuscript review was performed on the remaining 29 articles.
Nine studies were included in the final analysis providing a total sample of 1001 subjects (4,
25–32). Two full length articles in Chinese were translated to English, prior to analysis (32,
33).
Study Descriptions
The incidence of death among patients in the quantitative resuscitation groups ranged from
13% to 74% with a mean of 47% and in the control groups ranged from 27% to 72% with a
mean of 57%. Eight studies took place in the intensive care unit and one in the emergency
department (ED). Detailed description of included studies is shown in Table 2.
Quality Assessment
Three independent observers (JAK, NIS, ST) graded the studies with respect to the key quality
variable of concealment of allocation; consensus was reached by conference. Four studies were
assigned grade A, three studies were assigned grade B and two were assigned grade C (Table
2).
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Analyses
When all nine studies were considered, there was evidence of both statistical heterogeneity
(p = 0.07, I2 = 45%) and clinical heterogeneity among the studies. The summary OR
demonstrates a significant reduction in mortality (OR 0.64, 95% CI 0.43–0.96) among subjects
receiving quantitative resuscitation (Fig. 2). To assess for potential publication bias, a funnel
plot of all included studies is provided in Figure 3. Egger regression analysis revealed no
significant indication of publication bias (intercept = 0.61, 95% CI − 2.4–3.6, p = 0.65).
Studies within the two subgroups defined a priori (early vs. late) were combined and the results
are shown in Figure 2. Among the early quantitative resuscitation studies (n = 6 studies), there
was minimal heterogeneity (p = 0.40, I2 = 2.4%). The overall mortality rate in the early
quantitative resuscitation group was 39%. Patients randomized to receive early quantitative
resuscitation compared with standard resuscitation had a significantly lower mortality rate (OR
0.50, 95% CI 0.37 – 0.69). Results were robust to sensitivity analysis; when the lower quality
studies (grades B and C) were excluded, the results in the early quantitative resuscitation
subgroup were similar (OR 0.60, 95% CI 0.35–1.0). In the late quantitative resuscitation group
(n = 3 studies) the overall mortality rate was 64%. Patients randomized to late quantitative
resuscitation did not have a significantly different mortality rate compared with standard
resuscitation (OR 1.16, 95% CI 0.60 –2.22). None of the above point estimates were
significantly different when using a fixed effect model.
Given that early quantitative resuscitation had such a clear impact on mortality, we performed
a post hoc sensitivity analysis in which we step wise excluded each study individually and
reanalyzed the pooled OR for the early subgroup to determine whether any individual study
had an overwhelming influence on the results. None of the point estimates changed during this
analysis and the 95% CI only widened slightly but remained well below 1.0.
DISCUSSION
This meta-analysis evaluates the treatment effect of using a quantitative resuscitation strategy
in the treatment of patients with sepsis. Using pooled data from nine studies that randomized
a total of 1001 subjects, we found the magnitude of the decrease in mortality (OR 0.50 with
the upper limit 95% CI 0.69) was profound when the resuscitation strategy was implemented
early. The benefits of a quantitative resuscitation strategy seem to be completely lost if the
intervention is initiated late. Our results provide the strongest support to date for the Surviving
Sepsis Campaign recommendation of providing quantitative resuscitation at the time of severe
sepsis recognition (5).
This systematic review used both a comprehensive search and standard methods for
summarizing the treatment effect of a quantitative resuscitation strategy in patients with sepsis.
Our subgroup analysis of early vs. late quantitative resuscitation pooled studies based on the
reported timing of the resuscitation intervention and this timing may not have been a part of
the original study methods. The limitations of making inferences based on between-study rather
than within-study comparisons have been well-described but our subgroup analysis was limited
to one hypothesis and was developed a priori based on the sound biological plausibility that a
quantitative resuscitation strategy may require early initiation to be effective (34).
The importance of the treatment benefit reported in this meta-analysis is underscored by the
continued high mortality rate among patients with severe sepsis. Three recently published
randomized control trials of medication treatments for severe sepsis and septic shock reported
28 day mortality rates between 30% and 60% (35–37). Furthermore, it is estimated that severe
sepsis cases account for >500,000 ED visits annually and that these patients stay an average
of 5 hr in the ED (38). Our findings suggest that applying an early quantitative resuscitation
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strategy in these patients at the time of recognition, such as in the ED or after immediate transfer
to an intensive care unit, would impart a substantial survival benefit.
Any meta-analysis is prone to bias due to its retrospective approach; however, we used a
number of important steps in an attempt to minimize its impact. First, we followed a protocol
that was written before starting the search and analysis. Second, we used independent observers
to both abstract data and grade study quality. We should note that in our original protocol we
proposed to grade the quality of the studies based on the criteria proposed by Jadad et al.
(39). However, these criteria were intended to be applied to classic therapeutic trials, such as
medication treatment studies, and after attempts to apply these criteria to the trials reviewed
in this meta-analysis, the consensus of the investigators was that they did not accurately
represent the quality of the studies. Therefore we report the Jadad score but did not use it as
our primary quality measure. Third, we constructed a funnel plot to assess for publication bias.
Visual inspection of the plot reveals a lack of studies in the left lower quadrant indicating the
potential that smaller studies demonstrating a significant reduction in mortality were not
identified. Finally, our meta-analysis addressed all of the suggested necessary components of
the AMSTAR methodologic quality measurement tool for systematic reviews (40). A
limitation of this meta-analysis is the possibility that unreported cointerventions (e.g.,
corticosteroids or intensive insulin therapy) may have influenced the results of included studies;
there was no practical way to capture or control for such interventions in this meta-analysis.
Several previous systematic reviews have addressed the treatment effect of quantitative
resuscitation or hemodynamic optimization in critically ill patients (13–14,16–17). Two of
these studies investigated the effect of attaining either physiologic or supraphysiologic values
in broad groups of critically ill patients such as pre- and postsurgical, trauma, sepsis, and acute
respiratory distress syndrome patients (14,16–17). Only one of the reviews specifically
investigated sepsis, however, the objective of this review was to determine the variation in the
resuscitation goals targeted and whether this variation was associated with differences in
outcome (13). Thus the present meta-analysis is markedly different from these prior systematic
reviews in that we investigated the treatment effect of a quantitative resuscitation strategy only
in patients with sepsis and analyzed the studies with respect to temporal timing of the
intervention.
It is important to note that several barriers to adoption of a quantitative resuscitation strategy
for sepsis in the ED have been identified (4,41,42). In fact, the majority of the studies in the
early subgroup of this meta-analysis did not start quantitative resuscitation until intensive care
unit admission leaving the possibility of some delay in treatment initiation among these studies.
Although implementation requires that organizational and resource barriers be overcome, a
number of reports have documented successful implementation of such programs (43–46).
Additionally, we observed distinct variations in the goals or end points targeted among the
studies included in this analysis (Table 2). It was not an aim of the present investigation to
determine whether any particular resuscitation end point was superior but rather to determine
whether a quantitative resuscitation strategy (regardless of the endpoint) affected survival.
Future investigations should compare the relative efficacy of various quantitative resuscitation
endpoints in a randomized study design.
CONCLUSION
Data synthesized from nine randomized controlled trials demonstrate a clear survival benefit
afforded by quantitative resuscitation to treat sepsis at or near the time of recognition. The
benefit of quantitative resuscitation seems to be completely lost if the intervention is initiated
late. Future studies should investigate the optimal endpoints of quantitative resuscitation for
sepsis.
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APPENDIX
The Emergency Medicine Shock Research Network investigators are Alan E. Jones, Stephen
Trzeciak, Nathan I. Shapiro, and Jeffrey A. Kline.
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Figure 1.
Search, inclusion, and exclusion flow diagram.
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Figure 2.
Forest plot of all included studies and of the subgroup analysis of early vs. late quantitative
resuscitation using a random effects model. OR, odds ratio; CI, confidence interval; df, degrees
of freedom.
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Figure 3.
Funnel plot of included studies. Individual included studies are represented by dots and are
plotted by the standard error (SE) of the log odds ratio (OR) on the y-axis and the OR on the
x-axis. The pooled OR calculated using a random effects model is represented by the vertical
dotted line. This plot is provided for visual inspection for detection of publication bias.
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Table 1
Primary reasons for study exclusion
No. Reports
After relevance screen
  Review/letter/editorial 220
  Nonrandomized/nontreatment study 450
  Wrong focus/wrong population 204
Total 874
After full manuscript review
  Review paper 1
  Nonrandomized 5
  Wrong outcome 4
Total 10
After author contact
  No true experimental design 5
  Wrong outcome 1
  Wrong population 1
  Failed author contact 1
  Positive author contact but unusable data 2
Total 10
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